Get started

Press Releases

Delayed 3m

Fastest customizable press release feed in the world.

Signed out · 3-min delay · Sign up for real-time

Updates arrive automatically.

  • DISCO Announces Third Quarter 2026 Financial Results
    PR·

    DISCO Announces Third Quarter 2026 Financial Results

    Total Revenue of $45.3 Million, A Year over Year Increase of 11%, or 15% when Excluding the Contingent Matter in Q3 2025 CS Disco, Inc. ("DISCO") (NYSE:LAW) today announced financial results for its third quarter ended September 30, 2026. "DISCO had another strong quarter building AI for Litigators, paced by our sixth consecutive quarter of double-digit software growth, rapid growth in our DISCO Platform, which has grown 10x since Q1 2026, and continued customer enthusiasm for our unified litigation solution which just added a second cohort to our pilot program," said Eric Friedrichsen, CEO of DISCO. "Importantly, we also reached break-even Adjusted EBITDA in Q3 - a full quarter ahead o

    $LAW
  • Vishay Intertechnology Reports Third Quarter 2026 Results
    PR·

    Vishay Intertechnology Reports Third Quarter 2026 Results

    Vishay Intertechnology, Inc., (NYSE:VSH), one of the world's largest manufacturers of discrete semiconductors and passive electronic components, today announced results for the fiscal third quarter ended October 3, 2026. Highlights 3Q 2026 revenues of $978.9 million3Q 2026 gross margin was 25.5%3Q 2026 operating margin was 9.4%3Q 2026 diluted EPS of $0.373Q 2026 book-to-bill of 1.29 with book-to-bill of 1.28 for semiconductors and 1.31 for passive componentsBacklog at quarter end was 6.6 months "Q3 revenue of $979 million marked the highest quarterly revenue ever in Vishay’s history and exceeded the top end of our guidance. With rev

    $VSH
  • DISCO Announces Senior Hires to Accelerate AI for Litigators
    PR·

    DISCO Announces Senior Hires to Accelerate AI for Litigators

    New senior leaders in Engineering, Marketing to help drive continued velocity in Litigation AI DISCO (NYSE:LAW), a creator of industry-leading litigation technology, today announced two significant additions to its senior leadership team as it accelerates its strategy to lead in AI for Litigators. Mich Razon has joined as Chief Technology Officer, and Johann Wrede joined as Chief Marketing Officer. Both are long-tenured technology veterans with decades of experience spanning the legal, financial services, SaaS, cloud computing and travel industries. "DISCO continues to lead in AI for Litigators, and I am thrilled to see that mission resonate so strongly with high-caliber industry vete

    $LAW
  • Navios Maritime Partners L.P. Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2026
    PR·

    Navios Maritime Partners L.P. Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2026

    Net income: $185.7 million for Q3 2026$459.9 million for 9M 2026 Earnings per common unit: $6.42 for Q3 2026$15.83 for 9M 2026 Net cash from operating activities: $235.4 million for Q3 2026$548.7 million for 9M 2026 EBITDA: $293.9 million for Q3 2026$781.7 million for 9M 2026 Returning capital to unitholders: 141,392 common units repurchased in Q3 2026 for $12.0 million$0.06 cash distribution per unit for Q3 2026; $0.24 per unit annualized for 2026 Sales and purchases in Q3 – Q4 2026 QTD: $703.2 million acquisition cost of seven newbuilding vessels $30.8 million gross sale price for one capesize vessel; age of 17 yearsTwo newbuilding vessels delivered $5.0 billion contracted revenue as of O

    $NMM
  • The New York Times Company Reports Third-Quarter 2026 Results
    PR·

    The New York Times Company Reports Third-Quarter 2026 Results

    The New York Times Company (NYSE:NYT) announced today that its third-quarter 2026 financial results are available on The New York Times Company’s investor relations website at investors.nytco.com. As previously announced, The New York Times Company will host its earnings conference call today at 8:00 a.m. E.T. to discuss these results. A live webcast of the earnings conference call will be available at investors.nytco.com. Participants can pre-register for the telephone conference at https://dpregister.com/sreg/10212462/1050528acf2, which will generate dial-in instructions allowing participants to bypass an operator at the time of the call. Alternatively, to access the call without pre-re

    $NYT
  • CDW Declares Quarterly Cash Dividend of $0.680 Per Share
    PR·

    CDW Declares Quarterly Cash Dividend of $0.680 Per Share

    Reinforces Ongoing Commitment to Delivering Value to Stockholders CDW Corporation (NASDAQ:CDW) announced today that its Board of Directors declared a quarterly cash dividend of $0.680 per common share to be paid on December 10, 2026, to all stockholders of record as of the close of business on November 25, 2026. This amount represents approximately an 8 percent increase over last year's dividend and is aligned with the target of 25 percent of the trailing-twelve-month Non-GAAP net income through September 30, 2026. "Dividends represent an important component of our capital allocation priorities, along with share repurchases, strategic M&A, and managing our capital structure," said Alber

    $CDW
  • Lifecore Biomedical Reports Financial Results for the Third Quarter Ended September 30, 2026, and Provides Corporate Update
    PR·

    Lifecore Biomedical Reports Financial Results for the Third Quarter Ended September 30, 2026, and Provides Corporate Update

    Lifecore Biomedical, Inc. (NASDAQ:LFCR) ("Lifecore"), a fully integrated injectables contract development and manufacturing organization ("CDMO"), today announced results for the third quarter and nine months ended September 30, 2026. CEO Commentary "During the third quarter, Lifecore secured two new technology transfer projects. One will support process performance qualification (PPQ) batches for a biotech company’s new drug application (NDA) for a new chemical entity, and the other will support a currently marketed product for a large pharmaceutical company. We bel

    $LFCR
  • Unicycive Therapeutics to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference
    PR·

    Unicycive Therapeutics to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference

    Unicycive Therapeutics, Inc. ("Unicycive" or the "Company") (NASDAQ:UNCY), a biotechnology company developing therapies for patients with kidney disease, today announced that Shalabh Gupta, M.D., Chief Executive Officer, will present at the Guggenheim 3rd Annual Healthcare Innovation Conference on Tuesday, November 10, 2026, at 2:30 p.m. ET. A link to the live and archived webcast may be accessed on the Unicycive website under the Investors section: Events and Presentations. About Unicycive Therapeutics Unicycive Therapeutics is a biotechnology company developing novel treatments for kidney diseases. Unicycive’s lead investigation

    $UNCY
  • uniQure Announces Third Quarter 2026 Financial Results and Provides Company Update
    PR·

    uniQure Announces Third Quarter 2026 Financial Results and Provides Company Update

    ~ FDA granted priority review of BLA for ifezuntirgene inilparvovec (AMT-130) in Huntington’s disease; PDUFA target action date of May 1, 2027 ~ ~ Aligned with FDA on key elements of confirmatory study design; U.S. patient screening expected to begin by end of 2026 ~ ~ Cash, cash equivalents and investment securities of approximately $768.4 million as of September 30, 2026 expected to fund operations into 2030 ~ ~ uniQure to host earnings call at 8:30 a.m. ET ~

    $QURE
  • Avista Corp. Reports Q3 2026 Financial Results, Confirms 2026 Utility Earnings Guidance
    PR·

    Avista Corp. Reports Q3 2026 Financial Results, Confirms 2026 Utility Earnings Guidance

    Avista Corp. (NYSE:AVA) today reported the following results for the third quarter of 2026 and the nine months ended Sept. 30, 2026 as compared to the respective periods in 2025 (dollars in millions, except per-share amounts):1 Third Quarter Year-to-Date 2026 2025 2026 2025 Net income based on GAAP $49 $29 $176 $122 Earnings per diluted share based on GAAP $0.57 $0.36 $2.11 $1.51 Non-GAAP utility earnings1 $33 $30 $147 $135 Non-GAAP utility earnings per diluted share1 $0.38 $0.37 $1.76 $1.67 Avista Corp. is confirming its 2026 non-GAAP utility earnings guidance2 with a range of $2.52 to $2.72 per diluted sh

    $AVA
  • Geron Corporation Reports Third Quarter 2026 Financial Results and Recent Business Highlights
    PR·

    Geron Corporation Reports Third Quarter 2026 Financial Results and Recent Business Highlights

    Achieved $60.1 million in RYTELO® (imetelstat) net product revenue in Q3 2026, an increase of 5% compared to Q2 2026 Reiterated 2026 RYTELO net product revenue at the mid-to-high end of the $220 million to $240 million range; lowered 2026 total operating expenses range to $220 million to $230 million Initiated gated commercial launch to expand RYTELO access to eligible LR-MDS patients in targeted European markets, with availability expected in Germany by end of year Ended Q3 2026 with cash, cash equivalents, restricted cash, and marketable securities of $339 million Company to host conference call and webcast today, November 4, 2026, at 8:00 a.m. ET FOSTER CITY, Calif., Nov. 04, 202

    $GERN
  • Kraft Heinz to Divest North America Coffee Business to One Rock Capital Partners
    PR·

    Kraft Heinz to Divest North America Coffee Business to One Rock Capital Partners

    Transaction supports Company’s growth strategy by unlocking value and further focusing resources and investments on priority brands The Kraft Heinz Company (NYSE:KHC) ("Kraft Heinz" or the "Company") today announced that it has entered into a definitive agreement with an affiliate of One Rock Capital Partners, LLC (together with its affiliates, "One Rock"), to divest its North America coffee business (the "Business") at an enterprise value of $650 million. Kraft Heinz will retain a 30% non-controlling equity stake in the Business. One Rock is a value-oriented, operationally focused private equity firm with in-depth experience in the food and beverage sector. This press release features m

    $KHC
  • Kraft Heinz Announces Two New Members to Its Board of Directors
    PR·

    Kraft Heinz Announces Two New Members to Its Board of Directors

    New Independent Directors bring deep consumer, financial and operational expertise – strengthening the Board as Kraft Heinz advances its transformation strategy The Kraft Heinz Company (NYSE:KHC) ("Kraft Heinz" or the "Company") today announced that Kelly Dilts and J. Michael (Mike) Schlotman have been appointed to its Board of Directors ("Board"), effective Nov. 4, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261104847499/en/J. Michael (Mike) Schlotman "We are pleased to welcome Kelly and Mike to the Kraft Heinz Board," said John T. Cahill, Chairman of the Board of Kraft Heinz. "They bring highly relevant leadership e

    $KHC
  • The Kraft Heinz Company Declares Regular Quarterly Dividend of $0.40 Per Share
    PR·

    The Kraft Heinz Company Declares Regular Quarterly Dividend of $0.40 Per Share

    The Kraft Heinz Company (NYSE:KHC) announced today that the Company’s Board of Directors declared a regular quarterly dividend of $0.40 per share of common stock payable on December 23, 2026, to stockholders of record as of December 4, 2026. ABOUT THE KRAFT HEINZ COMPANY Kraft Heinz (NYSE:KHC) is one of the world’s largest food and beverage companies, with approximately $25 billion in net sales in 2025 and a portfolio of iconic brands enjoyed by consumers in more than 40 countries. By investing in our capabilities and brands, including Heinz, Kraft, Philadelphia, Primal Kitchen, and Lunchables, we are unlocking the full power of our portfolio. We deliver high‑quality, great‑tasting, and

    $KHC
  • ARRAY Technologies Reports Financial Results for the Third Quarter 2026
    PR·

    ARRAY Technologies Reports Financial Results for the Third Quarter 2026

    Delivers Record $2.6 Billion Orderbook While Expanding into Adjacent Products and Markets Announced Agreement to Combine in a Stock-for-Stock Merger with Shoals Technologies Group, Inc., Creating an Integrated Energy Infrastructure Platform 2026 Third Quarter Business Highlights Record total executed contracts and awarded orders at September 30, 2026 of $2.6 billion, a 42% increase year-over-yearOver $1.8 billion of trailing twelve-month net new orders at a book-to-bill of 1.6xCompleted the acquisition of Affordable Wire Management (AWM) expanding the product portfolio into wire management and reaching the Battery Energy Storage System (BESS) and Datacenter marketsFormally launched Atlas™

    $ARRY
  • Shoals Technologies Group, Inc. Reports Financial Results for Third Quarter 2026
    PR·

    Shoals Technologies Group, Inc. Reports Financial Results for Third Quarter 2026

    – Quarterly Revenue of $195.3 million – – Income from Operations of $29.0 million – – Net Income of $17.9 million – – Adjusted EBITDA1 of $39.8 million – – Backlog and Awarded Orders of $791.7 million – – Provides Fourth Quarter and Raises Full-year Outlook –

    $SHLS
  • Viridian Therapeutics Reports Third Quarter 2026 Financial Results and Highlights Recent Business Progress
    PR·

    Viridian Therapeutics Reports Third Quarter 2026 Financial Results and Highlights Recent Business Progress

    - $24.7 million in Lumvoa™ (veligrotug-vvze) net product revenue with more than 100 patients on therapy at the end of Q3 2026 - - Elegrobart Biologics License Application (BLA) submission on track for Q1 2027 - - VRDN-008 phase 1 data disclosure on track for Q4 2026 - - VRDN-292, a potential best-in-class TSHR inhibitor, expected to initiate a phase 1 clinical trial in patients in Q4 2026 - - Cash, cash equivalents, and marketable securities of $955.2 million as of September 30, 2026 - - Company to host webcast today, November 4, at 8:00 a.m. ET - Viridian Therapeutics, Inc. (NASDAQ:VRDN), a biotechnology company focused on discovering, developing, and commercializing potentiall

    $VRDN